LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: Implication in invasion of prostate cancer cells

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Tapia, Tenekua ^a   Ottman, Richard ^a   Chakrabarti, Ratna ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; ILOMASTAT; INTERSTITIAL COLLAGENASE; LIM KINASE 1; DIPEPTIDE; ENZYME PRECURSOR; LIM KINASE; LIMK1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE 14; MEMBRANE PROTEIN; MMP2 PROTEIN, HUMAN; PRO MATRIX METALLOPROTEINASE 9; PRO-MATRIX METALLOPROTEINASE 9; PROTEINASE INHIBITOR; TGOLN2 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER INVASION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; ADULT; AGED; CELL MEMBRANE; CELL MOTION; CULTURE MEDIUM; DRUG ANTAGONISM; ENZYMOLOGY; GENE SILENCING; GENETICS; GOLGI COMPLEX; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN TRANSPORT; RNA INTERFERENCE; SECRETION; TRANSPORT VESICLE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CELL MEMBRANE; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; DIPEPTIDES; ENZYME PRECURSORS; GENE KNOCKDOWN TECHNIQUES; GOLGI APPARATUS; HUMANS; LIM KINASES; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; PROTEIN BINDING; PROTEIN TRANSPORT; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION; TRANSPORT VESICLES; UP-REGULATION; YOUNG ADULT;

EID: 78650966571     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-6     Document Type: Article

References (47)

1. Okano I, Hiraoka J, Otera H, Nunoue K, Ohashi K, Iwashita S, Hirai M, Mizuno K. Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs. J Biol Chem 1995, 270:31321-31330. 10.1074/jbc.270.52.31321, 8537403.
2. Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 2003, 278:36868-36875. 10.1074/jbc.M306196200, 12821664.
3. Yoshioka K, Foletta V, Bernard O, Itoh K. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 2003, 100:7247-7252. 10.1073/pnas.1232344100, 165861, 12777619.
4. Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer 2006, 118:2703-2710. 10.1002/ijc.21650, 16381000.
5. Davila M, Jhala D, Ghosh D, Grizzle WE, Chakrabarti R. Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer. Mol Cancer 2007, 6:40. 10.1186/1476-4598-6-40, 1913540, 17559677.
6. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998, 393:805-809. 10.1038/31729, 9655397.
7. Edwards DC, Gill GN. Structural features of LIM kinase that control effects on the actin cytoskeleton. J Biol Chem 1999, 274:11352-11361. 10.1074/jbc.274.16.11352, 10196227.
8. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1999, 1:253-259. 10.1038/12963, 10559936.
9. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998, 393:809-812. 10.1038/31735, 9655398.
10. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006, 206:1-8. 10.1002/jcp.20431, 15920734.
11. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25:9-34. 10.1007/s10555-006-7886-9, 16680569.
12. Li XY, Ota I, Yana I, Sabeh F, Weiss SJ. Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol Biol Cell 2008, 19:3221-3233. 10.1091/mbc.E08-01-0016, 2488283, 18495869.
13. Nagakawa O, Murakami K, Yamaura T, Fujiuchi Y, Murata J, Fuse H, Saiki I. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines. Cancer Lett 2000, 155:173-179. 10.1016/S0304-3835(00)00425-0, 10822133.
14. Yana I, Weiss SJ. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 2000, 11:2387-2401. 14927, 10888676.
15. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995, 270:5331-5338. 10.1074/jbc.270.10.5331, 7890645.
16. Wang Z, Juttermann R, Soloway PD. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000, 275:26411-26415. 10.1074/jbc.M001270200, 2683068, 10827175.
17. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 2001, 20:4782-4793. 10.1093/emboj/20.17.4782, 125610, 11532942.
18. Lehti K, Lohi J, Juntunen MM, Pei D, Keski-Oja J. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem 2002, 277:8440-8448. 10.1074/jbc.M109128200, 11779859.
19. Golubkov VS, Chekanov AV, Shiryaev SA, Aleshin AE, Ratnikov BI, Gawlik K, Radichev I, Motamedchaboki K, Smith JW, Strongin AY. Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation. J Biol Chem 2007, 282:36283-36291. 10.1074/jbc.M706290200, 17938169.
20. Nie J, Pei J, Blumenthal M, Pei D. Complete restoration of cell surface activity of transmembrane-truncated MT1-MMP by a glycosylphosphatidylinositol anchor. Implications for MT1-MMP-mediated prommp2 activation and collagenolysis in three-dimensions. J Biol Chem 2007, 282:6438-6443. 10.1074/jbc.M607337200, 17158888.
21. Remacle AG, Chekanov AV, Golubkov VS, Savinov AY, Rozanov DV, Strongin AY. O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). J Biol Chem 2006, 281:16897-16905. 10.1074/jbc.M600295200, 16627478.
22. Lafleur MA, Mercuri FA, Ruangpanit N, Seiki M, Sato H, Thompson EW. Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain. J Biol Chem 2006, 281:6826-6840. 10.1074/jbc.M513084200, 16407177.
23. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 2003, 308:386-395. 10.1016/S0006-291X(03)01405-0, 12901881.
24. Hoshino D, Tomari T, Nagano M, Koshikawa N, Seiki M. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion. J Biol Chem 2009, 284:27315-27326. 10.1074/jbc.M109.041400, 2785659, 19654316.
25. Wilson SR, Gallagher S, Warpeha K, Hawthorne SJ. Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate 2004, 60:168-174. 10.1002/pros.20047, 15162383.
26. del Peso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC. Rho proteins induce metastatic properties in vivo. Oncogene 1997, 15:3047-3057. 10.1038/sj.onc.1201499, 9444953.
27. Malliri A, Symons M, Hennigan RF, Hurlstone AF, Lamb RF, Wheeler T, Ozanne BW. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 1998, 143:1087-1099. 10.1083/jcb.143.4.1087, 2132955, 9817764.
28. Zhuge Y, Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier. J Biol Chem 2001, 276:16248-16256.
29. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995, 31:14-24. 10.1007/BF02631333, 7535634.
30. Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 2004, 279:39042-39050. 10.1074/jbc.M404958200, 15247230.
31. Munshi HG, Wu YI, Ariztia EV, Stack MS. Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. J Biol Chem 2002, 277:41480-41488. 10.1074/jbc.M207695200, 12194986.
32. Mallik I, Davila M, Tapia T, Schanen B, Chakrabarti R. Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells. Biochim Biophys Acta 2008, 1783:1737-1744. 10.1016/j.bbamcr.2008.05.006, 18541154.
33. Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 2004, 7:327-332. 10.1038/sj.pcan.4500750, 15356679.
34. Bonfil RD, Dong Z, Trindade Filho JC, Sabbota A, Osenkowski P, Nabha S, Yamamoto H, Chinni SR, Zhao H, Mobashery S, Vessella RL, Fridman R, Cher ML. Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase. A Pivotal Role in Bone Response and Intraosseous Tumor Growth. Am J Pathol 2007, 1899437, 17525276.
35. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000, 18:1135-1149.
36. Boghaert ER, Chan SK, Zimmer C, Grobelny D, Galardy RE, Vanaman TC, Zimmer SG. Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line. J Neurooncol 1994, 21:141-150. 10.1007/BF01052898, 7861190.
37. Golubkov VS, Boyd S, Savinov AY, Chekanov AV, Osterman AL, Remacle A, Rozanov DV, Doxsey SJ, Strongin AY. Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability. J Biol Chem 2005, 280:25079-25086. 10.1074/jbc.M502779200, 15878869.
38. Cao J, Chiarelli C, Kozarekar P, Adler HL. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis. Thromb Haemost 2005, 93:770-778.
39. Daja MM, Niu X, Zhao Z, Brown JM, Russell PJ. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis 2003, 6:15-26. 10.1038/sj.pcan.4500609, 12664060.
40. Sroka IC, Nagle RB, Bowden GT. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Neoplasia 2007, 9:406-417. 10.1593/neo.07193, 1877982, 17534446.
41. Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 2008, 121:3960-3970. 10.1242/jcs.031286, 19001503.
42. Vlecken DH, Bagowski CP. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells. Zebrafish 2009, 6:433-439. 10.1089/zeb.2009.0602, 20047470.
43. Rosel D, Brabek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanova K, Kollmannsberger P, Pankova D, Vesely P, Folk P, Fabry B. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008, 6:1410-1420. 10.1158/1541-7786.MCR-07-2174, 18819929.
44. Mishima T, Naotsuka M, Horita Y, Sato M, Ohashi K, Mizuno K. LIM-kinase is critical for the mesenchymal-to-amoeboid cell morphological transition in 3D matrices. Biochem Biophys Res Commun 392:577-581. 10.1016/j.bbrc.2010.01.075, 20100465.
45. Lin T, Zeng L, Liu Y, DeFea K, Schwartz MA, Chien S, Shyy JY. Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ Res 2003, 92:1296-1304. 10.1161/01.RES.0000078780.65824.8B, 12775580.
46. Rosso S, Bollati F, Bisbal M, Peretti D, Sumi T, Nakamura T, Quiroga S, Ferreira A, Caceres A. LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process extension in primary cultured neurons. Mol Biol Cell 2004, 15:3433-3449. 10.1091/mbc.E03-05-0328, 452595, 15090620.
47. Nishimura Y, Yoshioka K, Bernard O, Bereczky B, Itoh K. A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells. Histochem Cell Biol 2006, 126:627-638. 10.1007/s00418-006-0198-x, 16763828.